CLEARMIND MEDICINE INC (CMND) Stock News

USA - NASDAQ:CMND - CA1850534027 - Common Stock

1.01 USD

-0.02 (-1.61%)

Last: 9/16/2025, 3:07:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

CMND Latest News, Press Relases and Analysis

All

Press Releases

19 days ago - By: Benzinga - Mentions: IVA BOLT ENGN RLMD ...

12 Health Care Stocks Moving In Thursday's After-Market Session

a month ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

a month ago - By: SciSparc Ltd - Mentions: SPRC -

SciSparc-Clearmind Collaboration Leads to Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

a month ago - By: Clearmind Medicine Inc. - Mentions: SPRC

Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar

a month ago - By: Clearmind Medicine Inc.

Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

a month ago - By: Clearmind Medicine Inc.

Clearmind Medicine Receives IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Hadassah Medical Center

2 months ago - By: Clearmind Medicine Inc. - Mentions: SPRC

Clearmind Medicine Files International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

2 months ago - By: SciSparc Ltd - Mentions: SPRC

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

2 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder

2 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Completes Initiation of Leading Israeli Clinical Site for Phase I/IIa Trial of CMND-100 in Alcohol Use Disorder

2 months ago - By: Clearmind Medicine Inc.

Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled

2 months ago - By: Clearmind Medicine Inc.

Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces IRB Approval for Phase 1/2a Clinical Trial for Alcohol Use Disorder at Tel Aviv Sourasky Medical Center

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Expands Global Clinical Trial Targeting Multibillion-Dollar Alcohol Use Disorder Market

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Joins Forces with Leading US Political Firm to Promote Psychedelic Therapeutics

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Adds Leading Israeli Clinical Site to Its Ongoing Clinical Trial for Alcohol Use Disorder

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces Enrollment of First Patient in Phase I/IIa Clinical Trial for Alcohol Use Disorder Treatment

3 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces Enrollment of First Patient in Phase I/IIa Clinical Trial for Alcohol Use Disorder Treatment

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine to Host Live Webinar “Gazing Through the Crystal Ball” Featuring Leading Psychedelic Experts

4 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Announces Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction

4 months ago - By: Clearmind Medicine Inc. - Mentions: SPRC

Clearmind Medicine Announces Publication of European Patent for Psychedelic-Based Combination Therapy for Cocaine Addiction

5 months ago - By: Yahoo Finance - Mentions: CMPS APPF ET KMI ...

Why Compass Pathways Stock Was a Double-Digit Winner This Week

5 months ago - By: SciSparc Ltd - Mentions: SPRC

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

5 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

5 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Files International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders

5 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites

5 months ago - By: Clearmind Medicine Inc.

Clearmind Medicine Completes the Initiation of its Alcohol Use Disorder Phase I/IIa Clinical Trial at all Current Clinical Sites